HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USANA guidance

This article was originally published in The Tan Sheet

Executive Summary

Company expects sales of approximately $59 mil. in its fourth quarter ended Jan. 3, with total revenues of around $200 mil. in fiscal year 2003. CFO Gilbert Fuller is "very pleased" with the results, which reflect more than a 50% sales increase during the quarter "driven by continued growth in the number of active associates in both domestic and international markets." The firm said in October it planned to focus on the weight-loss market (1"The Tan Sheet" Oct. 20, 2003, p. 16). USANA will announce final fourth quarter and FY 2003 numbers during a Feb. 4 investors call...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS127662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel